I still believe EXAS will continue to drop until the CEO restructure the workforce. He need help from physicians and scientist to convince Cologuard is an excellent product and persuade USPSTF to change their recommendation asap. For now my recommendation is to HOLD on your shares. Sentiment: Hold
Of course cuts are coming. Managers have a "watercooler" to discuss it. Better hope you are on their good side.